Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma.

Autor: Kirkham M; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83201, USA., Kalivas A; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83201, USA., Fatema K; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83201, USA., Luelling S; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83201, USA., Dubansky BH; Department of Medical Laboratory Sciences & Public Health, Tarleton State University, Fort Worth, TX 76104, USA., Dubansky B; Department of Biological Sciences, University of North Texas, Denton, TX 76203, USA., Jones KB; Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA., Barrott JJ; Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83201, USA.; Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Jazyk: angličtina
Zdroj: International journal of molecular sciences [Int J Mol Sci] 2020 Apr 10; Vol. 21 (7). Date of Electronic Publication: 2020 Apr 10.
DOI: 10.3390/ijms21072636
Abstrakt: Synovial sarcoma, an uncommon cancer, typically affects young adults. Survival rates range from 36% to 76%, decreasing significantly when metastases are present. Synovial sarcomas form in soft tissues, often near bones, with about 10% demonstrating ossification in the tumor. The literature is inconclusive on whether the presence of ossification portends a worse prognosis. To this end, we analyzed our genetic mouse models of synovial sarcoma to determine the extent of ossification in the tumors and its relationship with morbidity. We noted higher ossification within our metastatic mouse model of synovial sarcoma. Not only did we observe ossification within the tumors at a frequency of 7%, but an even higher frequency, 72%, of bone reactivity was detected by radiography. An enrichment of bone development genes was associated with primary tumors, even in the absence of an ossification phenotype. In spite of the ossification being intricately linked with the metastatic model, the presence of ossification was not associated with a faster or worse morbidity in the mice. Our conclusion is that both metastasis and ossification are dependent on time, but that they are independent of one another.
Databáze: MEDLINE